13 days ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Analyst Ranking
Bottom 1%
#4164 out of 4174 analysts
Average Return
-18.77%
Win Rate
27%33 out of 122
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-07 - 2020-09-14 | Buy |
Turning Point Therapeutics IncTPTX | +208.74% | $35.13 | $108.46 | 2020-03-17 - 2021-03-17 | Buy |
Immunomedics IncIMMU | +158.98% | $32.30 | $83.65 | 2020-05-07 - 2020-09-14 | Buy |
Turning Point Therapeutics IncTPTX | +153.91% | $29.44 | $74.75 | 2022-03-22 - 2022-06-06 | Buy |
Springworks Therapeutics IncSWTX | +143.31% | $29.88 | $72.70 | 2020-04-14 - 2021-04-14 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zymeworks IncZYME | 8 | Hold | $8.00 | -15.61% | Reiterates | 13 days ago |
Fate Therapeutics IncFATE | 6 | Hold | $7.00 | +1.89% | Downgrades | 13 days ago |
Adc Therapeutics SaADCT | 7 | Buy | $20.00 | +331.97% | Maintains | a month ago |
Revolution Medicines IncRVMD | 6 | Buy | $32.00 | +23.55% | Maintains | 2 months ago |
Omega Therapeutics IncOMGA | 1 | Buy | $11.00 | +52.35% | Initiates Coverage On | 2 months ago |
Portage Biotech IncPRTG | 3 | Buy | $21.00 | +356.52% | Maintains | 2 months ago |
Ikena Oncology IncIKNA | 3 | Buy | $22.00 | +455.56% | Maintains | 2 months ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | +802.78% | Maintains | 3 months ago |
Kronos Bio IncKRON | 3 | Buy | $10.00 | +340.53% | Maintains | 3 months ago |
Prelude Therapeutics IncPRLD | 3 | Buy | $15.00 | +112.46% | Maintains | 3 months ago |
Repare Therapeutics IncRPTX | 3 | Buy | $25.00 | +102.27% | Maintains | 3 months ago |
Pmv Pharmaceuticals IncPMVP | 2 | Buy | $36.00 | +336.89% | Maintains | 3 months ago |
Neoleukin Therapeutics IncNLTX | 3 | Hold | N/A | N/A | Downgrades | 3 months ago |
Relay Therapeutics IncRLAY | 6 | Buy | $43.00 | +94.83% | Maintains | 3 months ago |
Macrogenics IncMGNX | 6 | Buy | $12.00 | +114.67% | Maintains | 3 months ago |
Igm Biosciences IncIGMS | 4 | Buy | $45.00 | +87.50% | Maintains | 3 months ago |
Replimune Group IncREPL | 2 | Buy | $48.00 | +69.67% | Maintains | 3 months ago |
Springworks Therapeutics IncSWTX | 9 | Buy | $99.00 | +212.40% | Maintains | 3 months ago |
Y Mabs Therapeutics IncYMAB | 4 | Buy | $19.00 | +305.98% | Maintains | 3 months ago |
Tango Therapeutics IncTNGX | 1 | Buy | $10.00 | +52.91% | Initiates Coverage On | 4 months ago |
Nurix Therapeutics IncNRIX | 4 | Buy | $53.00 | +323.32% | Maintains | 4 months ago |
Gt Biopharma IncGTBP | 2 | Buy | $5.00 | +458.66% | Maintains | 5 months ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | -0.05% | Downgrades | 5 months ago |
Nuvation Bio IncNUVB | 2 | Buy | $4.50 | +87.50% | Maintains | 5 months ago |
Caribou Biosciences IncCRBU | 2 | Buy | $27.00 | +255.26% | Maintains | 6 months ago |
Biontech SeBNTX | 10 | Buy | $272.00 | +91.47% | Maintains | 6 months ago |
Kinnate Biopharma IncKNTE | 1 | Buy | $33.00 | +338.83% | Initiates Coverage On | 6 months ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | -0.01% | Downgrades | 8 months ago |
Atara Biotherapeutics IncATRA | 3 | Buy | $29.00 | +460.93% | Maintains | 8 months ago |
Aadi Bioscience IncAADI | 4 | Buy | $48.00 | +283.08% | Maintains | 10 months ago |
Oric Pharmaceuticals IncORIC | 6 | Hold | N/A | N/A | Downgrades | 10 months ago |
Black Diamond Therapeutics IncBDTX | 2 | Hold | N/A | N/A | Downgrades | 10 months ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | a year ago |
Nucana PLCNCNA | 2 | Buy | $9.00 | N/A | Maintains | a year ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 2 years ago |
Viracta Therapeutics IncVIRX | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Allogene Therapeutics IncALLO | 1 | Buy | $43.00 | N/A | Maintains | 2 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 2 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 2 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.